Small intestine adenocarcinoma is a rare type of cancer that forms in the glandular cells lining the small intestine, a long tube responsible for digesting food and absorbing nutrients. Despite the small intestine making up 90% of the digestive tract’s length, only 3 to 5% of digestive tract cancers occur there, making diagnosis challenging and often delayed until the disease has advanced.

Epidemiology

Small intestine adenocarcinoma stands out as one of the rarest cancers affecting the digestive system. Only about 11,000 Americans receive a small intestine cancer diagnosis each year, representing less than 1% of all new cancer diagnoses in the United States.^[1] This rarity is particularly puzzling because the small intestine comprises approximately 90% of the digestive tract’s surface area and 70 to 80% of its length.^[1]

Among the different types of small intestine tumors, neuroendocrine tumors, which develop in hormone-producing cells, have become the most common type in recent years. Adenocarcinoma ranks as the second most common, accounting for about one-third of small intestine cancer cases.^[1] Experts note that while neuroendocrine tumors have steadily increased in Western countries, the reasons for this rise remain unclear.^[8]

The disease shows some demographic patterns worth noting. Small intestine cancer appears slightly more often in men than in women. Age plays a significant role too, as most people diagnosed with this condition are 65 years old or older.^[1] This age pattern suggests that accumulated changes in cells over many years may contribute to cancer development.

Small bowel adenocarcinoma carries among the worst prognosis of gastrointestinal cancers, partly because vague symptoms and the difficulty of examining the small intestine often lead to late-stage diagnosis.^[2] Many patients already have cancer that has spread to lymph nodes or distant parts of the body by the time they learn of their diagnosis.^[17]

Causes

Cancer begins when cells undergo changes in their genetic material, called mutations, that cause them to multiply without control. In small intestine adenocarcinoma, these changes occur in the glandular cells, which are specialized cells that line the inner surface of the small intestine and help with digestion.^[1] Over time, these abnormal cells accumulate and form a mass or tumor that can grow and potentially spread to other parts of the body.

Researchers believe that chronic inflammation plays a central role in triggering these cellular changes. Inflammation is the body’s response to injury or irritation, but when it persists for years or decades, it can damage cells and increase the likelihood of harmful mutations. This prolonged irritation is thought to gradually alter the cells in the small intestine, eventually leading them to become cancerous.^[1]

Several digestive conditions create this kind of chronic inflammation. Crohn’s disease, an inflammatory bowel condition that causes ongoing inflammation in the digestive tract, significantly increases the risk. Similarly, ulcerative colitis, another inflammatory bowel disease, can lead to persistent irritation that damages intestinal cells. Celiac disease, a condition where the immune system reacts to gluten, also causes chronic inflammation in the small intestine.^[1]

Lifestyle factors contribute to inflammation as well. Smoking introduces harmful chemicals into the body that can irritate digestive tissues. Alcohol consumption, especially in large amounts, can damage the lining of the intestines. Dietary patterns matter too—eating large amounts of red meat or foods high in saturated fat has been associated with increased risk, while diets rich in vegetables and dietary fiber appear to offer some protection.^[1][17]

Genetic factors also influence risk. Research has found similarities between small and large intestine cancers, suggesting they may share underlying causes. People who develop cancer in either location face increased risk of developing cancer in the other part of the intestine.^[17] This connection hints at shared genetic or environmental factors affecting both areas of the digestive system.

Risk Factors

A risk factor is anything that increases a person’s chance of developing a disease. Having one or more risk factors doesn’t guarantee someone will get cancer, and some people develop the disease without any known risk factors. Understanding these factors helps people and their doctors stay vigilant for early signs.

Eating patterns significantly influence risk. Diets high in fat, particularly saturated fat from animal sources, increase the likelihood of developing small intestine adenocarcinoma. Conversely, eating plenty of vegetables and foods high in dietary fiber may lower risk.^[3][17]

Several digestive conditions substantially raise the risk. Crohn’s disease, which causes inflammation anywhere in the digestive tract but frequently affects the small intestine, creates an environment where cancer is more likely to develop. The chronic irritation and repeated cycles of damage and healing may set the stage for cancerous changes. Celiac disease, where eating gluten triggers an immune reaction that damages the small intestine, also increases risk.^[3]

Inherited genetic syndromes play a role in some cases. Familial adenomatous polyposis (FAP) is a condition where people develop numerous polyps in their digestive tract, significantly increasing cancer risk in both the small and large intestines. People with hereditary nonpolyposis colorectal cancer (HNPCC), also known as Lynch syndrome, face elevated risk for small intestine cancer alongside their increased colorectal cancer risk.^[3][17]

Symptoms

Small intestine adenocarcinoma presents a diagnostic challenge because many people experience no symptoms during the early stages of the disease. When symptoms do appear, they tend to be vague and could point to many different digestive problems, making it difficult to recognize cancer as the underlying cause.^[1]

Abdominal pain or cramping is among the most common complaints. This discomfort typically occurs in the middle of the abdomen and may come and go. Some people describe it as a dull ache, while others experience sharper cramping sensations.^[1] The pain might worsen after eating if the tumor is partially blocking the intestine.

Unexplained weight loss concerns both patients and doctors. When someone loses weight without trying—without changing diet or exercise habits—it signals that something may be wrong with how the body is processing nutrients. In small intestine cancer, weight loss might result from decreased appetite, difficulty absorbing nutrients, or the body’s response to cancer.^[1]

Bleeding in the gastrointestinal tract produces noticeable changes in bowel movements. Blood might appear as fresh red streaks in the stool, or it could make the stool appear very dark or black, resembling tar. This darkening occurs when blood is digested as it passes through the intestines. Some people may not notice blood directly but develop anemia, a condition where the body doesn’t have enough healthy red blood cells, causing weakness and fatigue.^[1]

Digestive symptoms can significantly affect daily life. Indigestion, a feeling of discomfort or burning in the upper abdomen, may occur after meals. Bloating creates a sensation of fullness or tightness in the belly. Nausea and vomiting can make it difficult to eat normally. Diarrhea or other changes in bowel habits might develop. In severe cases, the tumor may grow large enough to cause a small bowel obstruction, blocking the passage of food through the intestine, which requires immediate medical attention.^[1]

Some symptoms indicate more advanced disease. Jaundice, where the skin and whites of the eyes turn yellow, may appear if cancer spreads to the liver or blocks the bile ducts. A noticeable lump in the abdomen could be felt if the tumor grows large. Trouble breathing might develop if the cancer spreads to the lungs or if severe anemia affects oxygen delivery throughout the body.^[1]

Prevention

While no guaranteed way exists to prevent small intestine adenocarcinoma, certain lifestyle choices and medical approaches may help reduce risk. These strategies focus on managing inflammation, maintaining overall digestive health, and addressing known risk factors.

Dietary modifications offer one of the most accessible prevention strategies. Limiting consumption of red meat and foods high in saturated fat may lower risk. Instead, building meals around vegetables, fruits, whole grains, and other high-fiber foods provides protective benefits. These plant-based foods contain vitamins, minerals, and other compounds that support digestive health and may help prevent cellular changes that lead to cancer.^[17]

For people with inflammatory bowel diseases like Crohn’s disease or celiac disease, properly managing these conditions becomes crucial. Following prescribed treatments, avoiding triggers (such as gluten for those with celiac disease), and working closely with healthcare providers to keep inflammation under control may reduce the long-term risk of developing cancer. Regular check-ups allow doctors to monitor the condition and adjust treatments as needed.

Lifestyle habits that reduce inflammation throughout the body may also help. Quitting smoking removes harmful chemicals that irritate digestive tissues and contribute to inflammation. Limiting alcohol consumption protects the intestinal lining from damage. Maintaining a healthy weight through balanced eating and regular physical activity supports overall digestive function and reduces chronic inflammation.^[1]

People with hereditary conditions like familial adenomatous polyposis or hereditary nonpolyposis colorectal cancer require specialized surveillance and prevention strategies. Genetic counseling can help these individuals understand their risks and work with specialists to develop appropriate monitoring plans. In some cases, preventive surgeries may be considered to remove polyps or affected sections of intestine before cancer develops.^[17]

Unfortunately, no screening tests are routinely performed for small intestine cancer in people without symptoms or risk factors. The small intestine’s location and length make it challenging to examine regularly, unlike the colon which can be checked with colonoscopy. This makes symptom awareness and prompt medical attention for concerning signs all the more important.^[1]

Pathophysiology

Understanding what happens in the body when small intestine adenocarcinoma develops helps explain why certain symptoms occur and why treatment approaches are chosen. The pathophysiology describes the abnormal changes that transform healthy intestinal tissue into cancerous growths.

The small intestine consists of three sections: the duodenum, which connects to the stomach; the jejunum, the middle section; and the ileum, which connects to the large intestine. Most adenocarcinomas develop in the duodenum, though they can occur anywhere along the small intestine’s length.^[1] This location matters because tumors in different areas may cause different symptoms and require different surgical approaches.

Adenocarcinomas begin in the glandular epithelial cells that line the inner surface of the small intestine. These specialized cells normally produce mucus and digestive enzymes that help break down food. When genetic mutations accumulate in these cells, they lose their normal regulatory controls and begin multiplying rapidly without the usual checks and balances that keep cell growth orderly.^[9]

As abnormal cells accumulate, they form a mass that gradually grows larger. The tumor may extend through the layers of the intestinal wall, which include the inner lining, muscle layers, and outer covering. As the tumor expands, it can narrow the opening inside the intestine, potentially blocking the passage of food. This explains why people may experience abdominal pain, cramping, or in severe cases, complete bowel obstruction.^[3]

The tumor may also erode blood vessels in the intestinal wall, leading to bleeding. Small amounts of bleeding over time can cause anemia, while larger bleeds produce visible blood in the stool. The cancer’s presence also disrupts the small intestine’s crucial role in absorbing nutrients from food. As the disease progresses, malnutrition may develop even when the person eats normally, contributing to weight loss and weakness.

In more advanced stages, cancer cells may break away from the primary tumor and travel through the lymphatic system or bloodstream to other parts of the body. The lymph nodes near the intestine are often the first sites where cancer spreads. From there, cancer may reach distant organs such as the liver, lungs, or peritoneum (the membrane lining the abdominal cavity). This process, called metastasis, significantly changes treatment options and prognosis.^[17]

The molecular changes underlying small intestine adenocarcinoma appear similar to those in colorectal cancer. This similarity explains why treatment approaches for small intestine adenocarcinoma are often adapted from strategies proven effective for colorectal cancer. Both cancers may involve similar genetic mutations and respond to similar chemotherapy drugs.^[1]